JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M509440200 on November 4, 2005

J. Biol. Chem., Vol. 281, Issue 2, 1224-1232, January 13, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/2/1224    most recent
M509440200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramsperger, A.
Right arrow Articles by Fischer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramsperger, A.
Right arrow Articles by Fischer, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Crystal Structure of an Archaeal Pentameric Riboflavin Synthase in Complex with a Substrate Analog Inhibitor

STEREOCHEMICAL IMPLICATIONS*

Arne Ramsperger{ddagger}12, Martin Augustin{ddagger}13, Ann-Kathrin Schott§4, Stefan Gerhardt{ddagger}4, Tobias Krojer{ddagger}5, Wolfgang Eisenreich§, Boris Illarionov§, Mark Cushman¶, Adelbert Bacher§, Robert Huber{ddagger}, and Markus Fischer§6

From the {ddagger}Max-Planck-Institut für Biochemie, Abteilung für Strukturforschung, Am Klopferspitz 18, D-82152 Martinsried, Germany, the §Lehrstuhl für Organische Chemie und Biochemie, Technische Universität München, Lichtenbergstrasse 4, D-85747 Garching, Germany, and the Department of Medicinal Chemistry and Pharmacology, Purdue University, West Lafayette, Indiana 47907

Whereas eubacterial and eukaryotic riboflavin synthases form homotrimers, archaeal riboflavin synthases from Methanocaldococcus jannaschii and Methanothermobacter thermoautrophicus are homopentamers with sequence similarity to the 6,7-dimethyl-8-ribityllumazine synthase catalyzing the penultimate step in riboflavin biosynthesis. Recently it could be shown that the complex dismutation reaction catalyzed by the pentameric M. jannaschii riboflavin synthase generates riboflavin with the same regiochemistry as observed for trimeric riboflavin synthases. Here we present crystal structures of the pentameric riboflavin synthase from M. jannaschii and its complex with the substrate analog inhibitor, 6,7-dioxo-8-ribityllumazine. The complex structure shows five active sites located between adjacent monomers of the pentamer. Each active site can accommodate two substrate analog molecules in anti-parallel orientation. The topology of the two bound ligands at the active site is well in line with the known stereochemistry of a pentacyclic adduct of 6,7-dimethyl-8-ribityllumazine that has been shown to serve as a kinetically competent intermediate. The pentacyclic intermediates of trimeric and pentameric riboflavin synthases are diastereomers.


Received for publication, August 26, 2005 , and in revised form, October 26, 2005.

The atomic coordinates and structure factors (code 2B98 (native enzyme) and 2B99 (DORL complex) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported by National Institutes of Health Grant UO1 CA89566 as well as by support from grants from the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, and the Hans-Fischer-Gesellschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 These authors have contributed equally to this work.

3 Present address: Proteros Biostructures GmbH, Am Klopferspitz 19, D-82152 Martinsried, Germany.

4 Present address: AstraZeneca, Protein Structure Laboratory, 26F14 Mereside, Alderley Park, Macclesfield SK104TG, England.

5 Present address: Inst. für Molekulare Pathologie (IMP), Dr. Bohrgasse 7, A-1030 Wien, Austria.

2 To whom correspondence may be addressed. Tel.: 49-89-8578-2678; Fax: 49-89-8578-3516; E-mail: ramsperg{at}biochem.mpg.de.

6 To whom correspondence may be addressed. Tel.: 49-89-289-13336; Fax: 49-89-289-13363; E-mail: markus.fischer{at}ch.tum.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
V. Zylberman, S. Klinke, I. Haase, A. Bacher, M. Fischer, and F. A. Goldbaum
Evolution of vitamin b2 biosynthesis: 6,7-dimethyl-8-ribityllumazine synthases of Brucella.
J. Bacteriol., September 1, 2006; 188(17): 6135 - 6142.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.